Evidence map›Paper›PMID 39206338›Full record

ArticleRadiology case reports2024

Recurrence of a dermatofibrosarcoma protuberans? Rare case.

Sohayb Darraz, Zakaria Khattab, Ilyesse Haichour, Omar Mokhtari, Amine El Farhaoui, Adnane Lachkar, Najib Abdeljaouad, Hicham Yacoubi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sohayb DarrazFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Zakaria KhattabFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Ilyesse HaichourFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Omar MokhtariFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Amine El FarhaouiFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Adnane LachkarFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Najib AbdeljaouadFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.
Hicham YacoubiFaculty of Medicine and Pharmacy, Mohammed I University, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dermatofibrosarcoma protuberans (DFS) is a mesenchymal-origin skin tumor with intermediate malignancy. Though rare, it's not exceptional, comprising about 0.1% of malignant skin tumors. The authors discuss clinical, radiological, histopathological studies, and various therapeutic modalities for this tumor. Our 82-year-old patient presented with a 3 cm swelling on the right arm, initially undergoing biopsy followed by surgical excision of the mass. Adjuvant treatment with radiotherapy or chemotherapy is unnecessary unless recurrence or malignant transformation occurs. Histological analysis is crucial for diagnosis. The preferred treatment method is wide surgical excision. Prognosis primarily depends on malignancy, especially at the local level, with a high risk of recurrence. It's rare for a distinctly malignant sarcomatous transformation with metastasis to occur.

Indexed as

CD34-positive tumorDermatofibrosarcoma protuberansSkin cancer

Identifiers

PMID39206338
PMCPMC11357827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.